• Combined adult-use and medical cannabis sales in Nevada reached nearly $530 million in 2018, the first full year of legal recreational sales
• The company’s acquisition of Vegas Valley Growers North in Las Vegas included production facilities, four state licenses and popular Nevada vape brand ‘Vegas M Stick’

National cannabis holding company IONIC Brands Corp. (CSE: IONC) (OTC: IONKF), formerly Zara Resources Inc., recently added to its multistate portfolio of award-winning cannabis brands with the purchase of Vegas Valley Growers North (“VVG”), a Las Vegas, Nevada, state-licensed cultivation and manufacturing firm for medical and recreational cannabis. The vertically-integrated, cash-flow positive opportunity brings IONIC additional projected 2019 revenue of $6.6 million, with expected gross profits of $3.1 million and EBITDA of $2 million, the company stated in a news release (http://ibn.fm/7jcbv).

“The Nevada cannabis market is one of the cornerstone markets in the U.S. for building cannabis brands,” IONIC Brands Chairman and CEO John Gorst stated in a news release. “With over 42 million visitors to Las Vegas per year, the VVG acquisition will provide our Ionic vape and Zoots edibles brands valuable exposure to national and international cannabis consumers.”

The VVG acquisition includes a leased 1,700-square-foot production facility and five state licenses for cultivation and manufacturing of both medical and recreational cannabis. VVG is also building a 60,000-square-foot manufacturing facility and has plans for a second 80,000-square-foot facility. Distribution licenses for both medicinal and recreational cannabis products are being processed by state regulators.

Also included in the acquisition was VVG’s popular Nevada vape brand, ‘Vegas M Stick’, which partners nicely with IONIC Brands’ flagship recreational branded product – a stylish and sophisticated premium vape pen line called ‘IONIC’ that has earned customer loyalty and a reputation as a consistent top 10 vape brand in Washington state.

“IONIC vape pens are the perfect complement to the Vegas M Stick. Together, these luxury brands are set to have a massive presence in the Nevada market for years to come,” VVG CEO Mitch Wilson added.

According to the Nevada Department of Taxation, combined adult-use and medical cannabis sales reached nearly $530 million in 2018 (the first full year of legal recreational sales) with the state collecting nearly $70 million in tax revenue. Nevada’s first year with a legal adult-use market exceeded revenue projections, and the state expects to see continued growth with revenues remaining strong in 2019, as the tax department detailed in a news release (http://ibn.fm/8Uztz).

Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in markets across the western United States (http://ibn.fm/ot63a). The company continues to strategically expand nationwide in an effort to remain a leader of the highest-value segments in the cannabis market.

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at  http://ibn.fm/IONKF

• SHRG owns and manages a variety of businesses specializing in the direct-selling industry
• The company recently appointed Garrett McGrath as chief impact officer and Sylvia McGrath as chief experience officer of Elepreneurs, LLC
• Elepreneurs is a wholly owned subsidiary of Sharing Services

Sharing Services Global Corporation (OTCQB: SHRG) is a diversified holdings company that’s committed to reshaping how today’s direct-selling entrepreneurs succeed in the world of network marketing. SHRG recently announced the appointments of Garrett McGrath as chief impact officer and Sylvia McGrath as chief experience officer for Elepreneurs (http://ibn.fm/cR4bT). The two professionals bring decades of experience to Elepreneurs, adding qualitative value to SHRG’s noteworthy leadership team.

Elepreneurs LLC, a wholly owned subsidiary of Sharing Services (http://ibn.fm/9rd7k), is expected to benefit from the addition of Garrett McGrath, who adds years of network marketing experience. McGrath boasts three decades of network marketing experience and has built mammoth networks in firms consisting of more than 150,000 distributors spanning 21 countries. He is also a highly reputed keynote speaker, leadership trainer and field liaison, and he has served as the president of the Association of Network Marketing Professionals (ANMP) since 2012.

With 25 years of marketing experience in the direct-selling industry, Sylvia McGrath is a multitalented executive. She has served as corporate vice president of marketing for a network marketing firm and as vice president of sales and marketing for a Fortune 500 clientele design firm.

“Garrett and Sylvia are two of the most respected, admired, and effective leaders in the network-marketing industry today,” Elepreneurs President Keith Halls stated in a news release. “They have always led an energetic and experienced network marketing team, and we are grateful to have them as part of the family.”

Sharing Services CEO John “JT” Thatch noted that the two appointments should further propel the company’s growth trajectory. “We are very pleased that the McGraths have decided to join the executive management team of Elepreneurs as the company continues to grow since launching its first products in December 2017,” Thatch added. “These two individuals will add great value to the already experienced team that has helped us be successful thus far in the marketplace, which includes our incredible Elepreneurs in the field.”

Nearly 1,000 participants attended Elepreneurs’ first annual event, its Happiness Convention in Dallas, Texas. Enthusiastic Elepreneurs from the United States, Canada, Mexico, Singapore and Hong Kong participated in the milestone convention. Imminent keynote speakers and motivational leaders such as Shawn Achor and Les Brown discussed important points and provided guidance to the budding home entrepreneurs.

Headquartered in Plano, Texas, Sharing Services adheres to its proprietary Blue Ocean Strategy to promote market growth. The powerful strategy implements three keys focused on growing a robust international channel of home-based entrepreneurs, known as Elepreneurs, and supporting them through the direct-selling channel to produce 100 percent organic growth.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• CannaPharmaRx is in the process of acquiring, funding and developing three significant cannabis cultivation sites in Ontario and British Columbia
• The company’s agreements with the facilities’ owners grant it access to cultivation sites that could return close to 300,000 pounds of product per year
• The global cannabis cultivation industry is expected to become a nearly $155 billion market by 2026

Real estate investment and early-stage pharmaceutical company CannaPharmaRx Inc. (OTC: CPMD) is advancing its plans to become a cannabis cultivator using proprietary formulation and drug delivery technology currently in development to expand in an industry that is evolving at an aggressive pace. Analysts at ResearchandMarkets.com measured global cannabis sales at $10.39 billion in 2017 and are predicting a CAGR of 35 percent to $154.82 billion by 2026 (http://ibn.fm/KcnKs).

During the past year, CannaPharmaRx has completed agreements that will grant it a 48,750-square-foot cannabis grow facility in Hanover, Ontario; a 60,000-square-foot cannabis cultivation and grow facility in Stevensville, Ontario; and a 759,000-square-foot cannabis grow facility in Okanagan Falls, British Columbia, once funding to complete construction of the facilities is established.

The Stevensville facility is the first of the projects to be completed, but final acquisition depends upon CannaPharmaRx’s strategy to obtain all of the facility owner’s stock. Additional purchases of stock from other shareholders in the company, GN Ventures Ltd., are expected to be completed this year.

The Hanover facility is the next furthest along in development at this point. Exterior construction of the building has been completed, but interior construction has yet to begin. Once the facility is completed, it will contain up to 20 separate growing rooms with a projected annual production capacity of 9,500 kilograms of cannabis (20,900 pounds), according to CannaPharmaRx (http://ibn.fm/cEefr). Completion of the build-out of the facility is expected to take an estimated 20 weeks.

The Hanover facility was acquired through an agreement with Alternative Medical Solutions Inc. (AMS) in November. AMS has filed a cultivation application with Health Canada, which requires completion of the building as part of a phased approach toward finalizing the license.

The Okanagan Falls facility is still in the early stages of construction. It was acquired through a securities purchase agreement with Sunniva Inc. for a 116-acre parcel of land. Plans for the facility call for a two-phase development. The first phase is to construct 458,000 square feet comprising eight separate growing rooms expected to produce 60,000 kilograms (120,000 pounds) of cannabis flower per year. The second phase would involve an additional 301,000 square feet with similar production estimates.

Completion of the phase one buildout is expected to take 12 months, once financing is finalized.

“We are excited to have reached an agreement to purchase this property from Sunniva,” CEO Dominic Colvin stated in a June news release (http://ibn.fm/YAi4C). “The acquisition and development of the Okanagan Falls property, combined with our Hanover, Ontario, property and ownership interest in GN Ventures Ltd., sets the stage for the next step in CannaPharmaRx’s growth strategy to become a significant player in the Canadian cannabis industry while continuing to strive to maximize shareholder value.”

CannaPharmaRx is also working toward a public listing on a Canadian stock exchange later this year (http://ibn.fm/35XYZ).

For more information, visit the company’s website at www.CannaPharmaRx.com

• Citing larger distributor and private-label orders, VPRB reported revenues of $1.58 million for Q2 2019
• The company also reported a 31 percent increase in sales
• VPRB attained an uplisting to the OCTQB Venture Market

VPR Brands LP (OTCQB: VPRB), a multi-vertical, tiered company in the cannabis space, has increased its sales significantly through larger distributor and private-label orders, growing its quarterly figure to $1.58 million for the three-month period ended June 30 to record a 31 percent increase over the same period of 2018. VPRB also reported a 31 percent year-over-year sales increase for the six months ended June 30, 2019 (http://ibn.fm/D1B97).

As the company’s sales jumped, VPRB also achieved an OTCQB uplisting, reflecting its current reporting status, as well as annual verification and management certification. The company noted that such a move helps build shareholder value and enhances liquidity and fair valuation (http://ibn.fm/4WE6y).

“The results of putting our newly raised capital to work in Q2 were increased sales and larger distributor and private-label orders, which are key components to our growth strategy and will allow the company to continue to increase revenues and scale the business going forward,” VPRB CEO Kevin Frija stated in a news release.

VPRB anticipates being able to decrease product costs as it reaches larger volume, allowing it to achieve its target 40 percent margins. “In the second quarter of 2019, VPR Brands was able to invest in expanding product lines and on hand inventory to be able to acquire new distributors‎ and better meet demand,” added VPRB COO Dan Hoff. “‎Launching our new variable voltage twist battery played a big part in gaining entry level product market share in the below $25.00 MSRP range.”

VPRB is innovating the vaping experience through its new product, HoneyStick Brand BeeBox Pro Device. This innovation is an integral part of the company’s growth strategy. The new unit enables users to monitor battery life on an LCD screen. The device is also power adjustable to permit dial-in intensity levels for vaping. The result is that users can have a customized experience, controlling cloud, taste and activation. “This is a must-have device for anyone who vapes both nicotine and cannabis, the best of both worlds,” noted Frija (http://ibn.fm/OeeH0).

Another component aiding the growth of VPRB is the depth of the company’s management experience. Frija has 29 years of experience in the areas of sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. COO Dan Hoff has been in the vaporizer and e-cigarette industry at Vapor Corp. since the company’s inception in 2007. He has been with VPRB since 2016. Senior sales executive Gary Rep joined VPRB in 2018 but worked for a decade as vice president of sales and marketing at his previous company. VPRB also has senior and experienced management in web design, graphics, importing, international sales and other team positions.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• Trxade Group is actively working to reverse a negative phenomenon known as ‘pharmacy deserts’ that is affecting many parts of the U.S.
• Trxade is providing a solution that empowers small, independent pharmacies by giving them access to competitive pricing and reliable supply options
• Due to the demand, Trxade Group is also working on new product offerings that will expand the predictive analytical capabilities of community-based and independent pharmacies

As independent pharmacy businesses struggle to overcome various challenges, the U.S. is facing a growing problem with the so-called ‘pharmacy deserts’ phenomenon, which results in entire areas left without pharmacy services. One of the main reasons that so many smaller, independent industry players close down shop is that they cannot successfully compete against large pharmaceutical chains. Companies like Trxade Group Inc. (OTCQB: TRXD) are working to reverse the trend.

Trxade Group is an integrated pharmaceutical services company that has developed a web-based purchasing platform for transactions between independent pharmacies and drug distributors. The system is characterized by an optimum buyer/seller pricing algorithm, information about product availability and predictive data analytics.

Of more than 65,000 pharmacy facilities operating in the U.S., 24,000 are independent. The aim of the Trxade’s platform is to support local, independent pharmacies through the identification of the best sourcing and pricing opportunities for prescription drugs.

Independent pharmacies struggle due to the large capacity of national and international drugstore chains. These chains acquire products in bulk, which means that their supplies are available at a reduced cost in comparison to what a smaller, independent pharmacy would get as a price quote.

Additionally, problems arise from the work of the pharmacy benefit managers (PMBs) who process claims. Currently, PMBs work for Medicare, Medicaid and commercial health plans with the intent to reduce benefits for the pharmacies to bring down expenses for insurers. The situation with state Medicaid patient coverage has become so troublesome that numerous independent pharmacies across the U.S. have had to discontinue operations.

Reports suggest that the absence of independent community pharmacies is harming patients. Local businesses are perceived as members of the community, and the pharmacists working at independent enterprises often go the extra mile to ensure the availability of important medications for elderly or disabled patients.

Trxade Group is constantly working to empower independent and community-based small pharmacies. Apart from its already established platform, TRXD is also planning the launch of new products in the near future.

New product offerings have been developed to address customer demand, offering increased data analytics capability and better inventory/cost management, as TRXD Chairman and CEO Suren Ajjarapu detailed in a news release.

TRXD’s network of independent pharmacies is also growing rapidly. By the end of June 2019, the company had registered the addition of 390 new independent pharmacies to its platform. This number represents an increase of 24 percent on a quarterly basis and of 137 percent on an annual basis.

The company’s current trading software membership has reached the impressive 10,500 pharmacies milestone. This massive number and the growth registered so far in 2019 have TRXD optimistic about the future.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• Women’s health and access to medical amenities are huge concerns in both developed and developing nations
• ETST’s wholly owned subsidiary, Earth Science Pharm Inc., is dedicated to research, with a goal of eradicating STIs
• The company has launched Hygee, its home detection kits for screening STIs

Earth Science Tech Inc. (OTCQB: ETST) is a Florida-based biotech company engaged in the production of premium-quality industrial hemp and cannabis/cannabidiol (CBD) products. ETST offers 100 percent organic and pure CBD oil, which is made using the supercritical CO2 liquid-extraction process.

An innovative product aimed at improving women’s ability to self-screen for STIs was recently released by one of ETST’s subsidiaries. This kit, known as the Hygee, has the potential to revolutionize the arena of sexual health, empowering women through its innovative design.

Earth Science Pharma Inc., one of three wholly owned subsidiaries of ETST, is an emerging medical-research company engaged in the development of low-cost medical devices, testing processes, noninvasive diagnostic tools and vaccines for sexually transmitted infections and/or diseases (http://ibn.fm/WJSKk). The company’s research and development efforts are being conducted under the guidance and leadership of CEO and Chief Science Officer Michel Aube.

Earth Science Pharma is specifically focusing on developing and bringing to market medical devices and vaccines that focus on improving the health of women. Women’s health and access to medical amenities are huge concerns in both developed and developing nations. The company recently launched MSN-2, its first medical device, as a part of its initiative to meet the medical needs of women.

MSN-2 is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ETST named this innovative kit Hygee, after the French goddess of health (http://ibn.fm/ZQ2Zf). Hygee is a home-detection kit used for screening of STIs from a self-obtained gynecological specimen (http://ibn.fm/YLKCE). The kit includes a modified pantyliner, which is used to collect a sample of human cells that is sent to be analyzed in a laboratory using proven technology.

With MSN-2, modified pantyliners are worn by women for a duration of four hours – long enough to collect the specimen needed for laboratory tests. This kit can be ordered online and provides women with the ease of conducting tests in comfortable environments. Testing for STIs is essential for pregnant women, who must be screened for chlamydia infections to reduce the risk of transmitting the disease to their babies during childbirth.

The first production run of Hygee is underway, and initial marketing will target North America, South America, Asia and Africa. The company will package Hygee in English, French, Portuguese, Spanish, Vietnamese and Arabic in order to reach a wide audience of consumers.

“No other existing method of collecting genital specimens from women is more convenient or more efficient than Hygee,” Aube added in a news release (http://ibn.fm/kdJJ1). “With roughly 130 million new chlamydia cases diagnosed yearly, according to the [World Health Organization], Hygee is dedicated to this area of women’s health.”

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Cannabis investment building company Nabis Holdings is establishing a profile of synergistic and vertical properties across the United States
• The company recently announced an agreement to gain 100 percent of the membership units in a Phoenix-based medical marijuana asset, including a dispensary in a community that serves more than 132,000 unique patients
• The acquisition adds to Nabis’ already growing profile in the state, including a broad dispensary network, cultivation facility and greenhouse north of Phoenix
• Nabis expects its revenues to see a sharp increase during the next two years with its acquisition strategy

Vertically integrated cannabis specialty investment company Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) is growing its green profile in the desert of the Southwestern United States. Nabis announced August 12 that it has entered into a definitive agreement that will grant it 100 percent of an Arizona medical marijuana business’s membership units as a significant asset in a state where Nabis is cultivating a market presence.

The transaction, which is subject to the customary regulatory approvals and conditions for closing, is expected to expand Nabis’ position to 10 locations for retail, cultivation and processing facilities across the United States, including California’s world-leading marketplace and Michigan’s up-and-coming industry.

The new asset agreement grants Nabis access to a dispensary that operates in Phoenix’s metropolitan market area, serving more than 132,000 unique patients, according to Arizona Department of Health Services figures. A news release on the agreement states that the asset’s audited sales for 2017 and 2018 were $7.4 million and $8.7 million, respectively (http://ibn.fm/6cY5P).

“Entering Arizona is a key milestone in our business as we leverage our early-mover advantage to capitalize on one of the strongest limited-license, medical cannabis markets in the U.S.,” Nabis CEO and Director Shay Shnet stated in a news release. “We are confident that, given the revenue generation history of the business’ existing assets, combined with ongoing initiatives to further expand production and distribution capabilities, Nabis will be well positioned to capitalize on the dramatic growth of the cannabis market in Arizona.”

The asset has proprietary branded products and wholesale operations, including an established distribution network serving more than 50 percent of the dispensaries in Arizona, according to the news release. The Phoenix dispensary will be rebranded as Nabis once the transaction closes.

As of June, Arizona had 210,430 registered card holders eligible to consume medical-grade cannabis products.

A noteworthy acquisition for Nabis this year was that of Desert’s Finest, a 6,000-square-foot dispensary located in Desert Hot Springs, less than two hours east of Los Angeles and accessible to the nationally recognized Coachella Music Festival.

Desert’s Finest added more than 37,000 registered patients to Nabis’ growing list of customers. The dispensary reported more than $5.7 million in revenues over the previous year with a 47 percent gross profit margin.

For more information, visit the company’s website at www.NabisHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to NABIF are available in the company’s newsroom at http://ibn.fm/NABIF

• During the second quarter of 2019, Spectrum Global Solutions’ revenues reached $19.7 million
• A growth period started in the first quarter of the year and was mainly attributed to the expansion of Spectrum’s primary subsidiaries, including TNS Inc.
• Over the coming 12 months, Spectrum expects to win new contracts and expand into several key international markets

Spectrum Global Solutions Inc. (OTCQB: SGSI) recently announced that it received $3.7 million in new contracts during the second quarter of 2019 in a press release detailing the company’s financial results for the three-month period (http://ibn.fm/HagGQ).

Spectrum Global Solutions also entered into a definitive agreement for the acquisition of WaveTech GmBH, an innovative energy management technology firm. The agreement is expected to enable Spectrum to improve monetization of its existing customer base while expanding into new global markets.

During the second quarter of 2019, Spectrum witnessed strong revenue growth. Its total revenues reached $19.7 million, marking an increase of 29 percent on a quarterly basis. Gross profit during the second quarter was $1.2 million, or 13.9 percent of revenues.

The company brought down general and administrative expenses for Q2 2019 to $1 million (a reduction of 38 percent on an annual basis). Operating loss for the second quarter of the year went down by 21 percent on an annual basis.

Spectrum also reduced its ongoing interest expense by $0.3 million annually, converted approximately $3.7 million in debt at a 75 percent premium to the market and engaged MZ Group to implement an investor relations and financial communication program across all key markets.

“Taken together, we look forward to leveraging our strong foundation to execute on our significant backlog, win new contacts, and expand into several key international markets over the next 12 months. Ultimately, we expect these strategic steps to create long-term value for our shareholders,” Spectrum CEO Roger Ponder stated in a news release.

The results for the second quarter of the year continue a positive trend that was established during Q1 2019. In the first quarter of 2019, Spectrum registered revenue of $11.33 million, in comparison to the sales of $4.33 million that Spectrum accomplished in the first quarter of 2018 (http://ibn.fm/kd7v1).

The first quarter revenue was reflective predominantly of the consistent growth of the company’s primary subsidiaries, including TNS Inc. TNS is a Chicago-based Spectrum Global Solutions subsidiary that completes on-premise broadband capability enterprise expansion and operates nationwide, as well as in Mexico.

Spectrum Global Solutions is a leading single-source provider of end-to-end next generation network infrastructure and professional service solutions to carriers and corporate enterprises. The company works with clients across the U.S., Canada, Puerto Rico, the Caribbean and Guam.

Through its various subsidiaries, including TNS Inc., AW Solutions, ADEX Corporation and Tropical Communications Inc., Spectrum Global Solutions provides services directly to carriers, utilities, enterprises, aggregators, project management organizations and original equipment manufacturers (OEMs). Its subsidiaries enable the provision of comprehensive solutions to cover all aspects of fiber network and infrastructure.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

• MustGrow Biologics is developing mustard-based pest control products that can be sold on an industrial scale to help cannabis, fruit & vegetable, turf & ornamental and tobacco producers
• MustGrow’s non-synthetic focus on alternatives to chemical pesticides grants it a position of responsibility during an era when pesticide poisoning reports are increasing
• The company is turning its attention to the needs of the tobacco industry and the burgeoning cannabis industry in Canada

The ever pressing need to make produce available to people rather than the insects that prowl gardens and agricultural fields has led to the development of a wide array of pesticides since ancient times. Sacred Hindu text the Rigveda from about 4,000 years ago mentions the use of poisonous plants for pest control, for example (http://ibn.fm/ngyl4). However, chemical pesticides have caused alarm in modern times because of their association with illnesses that may afflict agricultural workers (http://ibn.fm/WdnZi), unborn children (http://ibn.fm/6kmKh), beneficial insects (http://ibn.fm/Z1uMj) and food consumers on an international scale (http://ibn.fm/Fqtv1).

Agriculture biotech company MustGrow Biologics Corp. (CSE: MGRO) is dedicated to developing and commercializing non-synthetic Allyl Isothiocyanate (AITC) from mustard seed as a natural fumigant that helps plants defend themselves against pests and harmful fungus activity, thereby providing an alternative to the synthetic pesticides that may harm people while trying to preserve the agricultural products they ingest.

MustGrow has specifically focused its development activity on supporting fruit & vegetable, turf & ornamental, tobacco and cannabis products in recent months as it has redirected its output from a granular based product approved by regulators for use in both Canada and the United States to a liquid form that may be particularly beneficial to these industries, as it is delivered through drip lines with increased concentration.

The company has 18 granted patents and nine pending applications for control of nematodes (parasitic ringworms), soil-borne diseases and other soil pests, according to its most recent filing statement with SEDAR (http://ibn.fm/Pv86N).

Bayer Global Segment Manager for FVI Crop Science Hartwig Dauck valued the biological crop protection market at about $2 billion in 2012, forecasting a compound annual growth rate (CAGR) of 15 percent in the following years, according to the statement. Analysts at Agribusiness Intelligence reported earlier this year that the global crop protection market grew six percent in 2018 to $57.5 billion (http://ibn.fm/9aHYA).

Although synthetic herbicides remained the dominant crop protection category globally, insecticide sales grew the most, raising its market share to 25.3 percent with $14.5 billion in sales.

MustGrow’s scientific focus this year is on using funds to optimize its liquid formulation and to research the potential for cannabis application. In addition, it is looking to bring in third party products for the cannabis market under distribution and in-licensing agreements. The first of these third party products includes an agreement with Triangle Plant Sciences (TPS) to offer exclusive Canadian and global access to TPS’s TP-1000, a bio-fertility product that, based on third party studies, can increase cannabis yields by approximately five percent, THC levels by 10 percent and terpenes by 22 percent.

“This is an exciting time to launch a TPS and MustGrow partnership that will deliver TPS’s best-in-class nutrient technology solutions for MustGrow’s high-value hydroponic applications, including cannabis in production legal geographies,” Senior Product Director at TPS Nick Favret stated after announcing the agreement last month. “Third party indoor trials have demonstrated excellent performance in hydroponic cannabis applications, with significant increases in terpene, and tetrahydrocannabinol (THC) concentration.”

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• Nanoemulsions play an important role in the cannabis formulation market, because they provide a reliable solution to bioavailability and insolubility problems
• The nanoemulsion market is expected to grow steadily and reach a value of $14.91 billion by 2025
• Geyser Brands has already established itself as a nanoemulsion pioneer through the development of its proprietary and highly effective NanoFusion technology

As cannabis edibles and beverages are becoming more popular, the nanoemulsions market is experiencing rapid growth. Nanoemulsion-infused cannabis beverages offer a solution to some of the most common problems that the sector is facing, including the limited efficacy of hemp-derived products caused by the insoluble nature of the molecules.

As a result, the global nanoemulsions market is expected to grow at a CAGR of 9.2 percent through 2025 to reach a value of $14.91 billion from just $6.78 billion in 2016 (http://ibn.fm/kfqLM). The legalization of cannabis products is one of the primary drivers of growth.

Insolubility problems can be addressed through the development of innovative solutions like nanoemulsion formulas. Nanoemulsions are advanced delivery systems that effectively transport therapeutic compounds into the body, enabling their effortless entry into the bloodstream for optimal effectiveness. They are stabilized fine oil/water dispersions that range in size from 20 to 600 nanometers (http://ibn.fm/RMcCQ).

Cannabis beverages based on nanoemulsion are fast acting and offer high bioavailability of active compounds. This means that the body is capable of absorbing cannabinoids in much higher amounts than typical. As a result, nanoemulsions can ensure a much better therapeutic or recreational experience.

Companies such as Geyser Brands Inc. (TSX.V: GYSR) are working to solve solubility and bioavailability problems through innovative developments. The NanoFusion technology by Geyser is made with natural materials to enhance penetration through the skin (in the case of topical product application) and improve the transportation and delivery of active ingredients across cell membranes.

Currently, NanoFusion is the only natural nanoemulsion on the market that features no solvents or inflammatory agents. In addition, it has no negative impact on the taste of beverages.

Apart from ensuring a high level of bioavailability, the NanoFusion technology also increases the shelf life of cannabis products. In addition, it makes it possible for consumers to rely on lower doses to obtain optimal therapeutic benefits from a product.

All of the products featured in Geyser’s diversified portfolio are based on NanoFusion technology. This means that the products have shown to be both reliable and capable of delivering consistent benefits to consumers.

Geyser Brands is a leading Vancouver-based consumer health care company that focuses on the development of high-quality cannabis products and brands. The company’s integrated production chain and formulation lab allow for the development of innovative products based on CBD for healthy lifestyle brands.

Geyser Brands relies on its subsidiary, Apothecary Botanicals, which operates a production facility that recently received its standard processing license from Health Canada. This license enables the company to enter the highly regulated Canadian market, with production set to begin later in 2019.

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR